Cancer Prevention Institute of California, Fremont, California.
Cancer Prevention Institute of California, Fremont, California; Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California.
J Urol. 2014 Apr;191(4):952-6. doi: 10.1016/j.juro.2013.10.075. Epub 2013 Oct 25.
Asian-American men with prostate cancer have been reported to present with higher grade and later stage disease than white American men. However, Asian-American men comprise a heterogeneous population with distinct health outcomes. We compared prostate cancer risk profiles among the diverse racial and ethnic groups in California.
We used data from the California Cancer Registry on 90,845 nonHispanic white, nonHispanic black and Asian-American men diagnosed with prostate cancer between 2004 and 2010. Patients were categorized into low, intermediate and high risk groups based on clinical stage, Gleason score and prostate specific antigen at diagnosis. Using polytomous logistic regression we estimated adjusted ORs for the association of race/ethnicity and nativity with risk group.
In addition to the nonHispanic black population, 6 Asian-American groups (United States born Chinese, foreign born Chinese, United States born Japanese, foreign born Japanese, foreign born Filipino and foreign born Vietnamese) were more likely to have an unfavorable risk profile compared to nonHispanic white men. The OR for high vs intermediate risk disease ranged from 1.23 (95% CI 1.02-1.49) for United States born Japanese men to 1.45 (95% CI 1.31-1.60) for foreign born Filipino men. These associations appeared to be driven by higher grade and prostate specific antigen rather than by advanced clinical stage at diagnosis.
In this large, ethnically diverse, population based cohort Asian-American men were more likely to have an unfavorable risk profile at diagnosis. This association varied by racial/ethnic group and nativity, and was not attributable to later stage at diagnosis. This suggests that Asian men may have biological differences that predispose to more severe disease.
据报道,亚裔美国男性的前列腺癌比美国白人男性表现出更高的分级和更晚期的疾病。然而,亚裔美国人是一个具有不同健康结局的多样化人群。我们比较了加利福尼亚州不同种族和族裔群体的前列腺癌风险特征。
我们使用了加利福尼亚癌症登记处 2004 年至 2010 年间诊断为前列腺癌的 90845 名非西班牙裔白人和亚裔美国男性的数据。根据临床分期、Gleason 评分和前列腺特异性抗原,将患者分为低危、中危和高危组。使用多项逻辑回归,我们估计了种族/族裔和原籍国与风险组之间关联的调整比值比(OR)。
除了非西班牙裔黑人人群外,6 个亚裔美国人族群(出生于美国的中国人、出生于国外的中国人、出生于美国的日本人、出生于国外的日本人、出生于国外的菲律宾人和出生于国外的越南人)与非西班牙裔白人男性相比,更有可能具有不利的风险特征。高 vs 中危疾病的 OR 范围从出生于美国的日本人的 1.23(95%CI 1.02-1.49)到出生于国外的菲律宾人的 1.45(95%CI 1.31-1.60)。这些关联似乎是由更高的分级和前列腺特异性抗原驱动的,而不是由诊断时的晚期临床分期驱动的。
在这个大型、种族多样化的基于人群的队列中,亚裔美国男性在诊断时更有可能具有不利的风险特征。这种关联因种族/族裔群体和原籍国而异,并且不能归因于诊断时的晚期阶段。这表明亚洲男性可能存在导致更严重疾病的生物学差异。